Vinge advised Creades in connection with a directed share issue

Vinge advised Creades AB (publ) in connection with a directed share issue of approximately SEK 1 billion to a number of institutional investors.

Vinge has advised Scandic Hotels Group AB (publ) on an offering of convertible bonds and an extension of the existing credit facilities

Vinge has advised Scandic Hotels Group AB (publ) on an offering of convertible bonds raising approximately SEK 1,609 million in gross proceeds and an extension of the existing SEK 6,650m credit facilities.

Vinge has advised Rotla on the sale of Centralpoint

Vinge advises Rotla B.V., a company controlled by Altor Fund IV and Kool Active B.V.,  in connection with the sale of Centralpoint Holding B.V., the leading IT value added reseller in the Benelux region, to Dustin.

Vinge has advised Corline Biomedical AB (publ) in connection with a directed share issue

The share issue was directed to a number of Swedish and international institutional investors on the basis of an accelerated bookbuilding process.

Vinge advises Klövern in connection with the public offer from Corem Property Group

Corem Property Group AB (publ) has announced a public offer to the shareholders of Klövern AB (publ). The total value of the offer amounts to approx. SEK 19.5 billion.

Vinge advises Embellence Group AB (publ) in connection with the listing on Nasdaq First North Premier Growth Market

Vinge advises Embellence Group AB (publ) (“Embellence Group”) in connection with the listing on Nasdaq First North Premier Growth Market. The offering circular was published on 15 March 2021 and first day of trading was on 24 March 2021.

Vinge advises Atairos in connection with its investment in MTG

MTG has raised approx. SEK 1.1. billion in a directed share issue through an accelerated book building procedure.

Vinge has advised CELLINK in connection with directed issues of SEK 3 billion

Vinge has advised CELLINK AB (publ) in connection with a directed issue of covertibles of SEK 1.5 billion and a directed issue of B-shares of SEK 1.5 billion, in total SEK 3 billion.

Vinge has advised Azelio in connection with a directed share issue of SEK 596 million

Vinge has advised Azelio in connection with a directed share issue whereby Azelio raises approximately SEK 596 million in issue proceeds before transaction costs.

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 1,106 million, before issue costs.

Vinge has advised Nick’s in connection with fund raising

Vinge has advised Nick’s, a food-tech brand offering sugar free snacks and ice cream, in connection with its largest investment round of USD 30 million.

Vinge has advised the arrangers in connection with Heimstaden’s EUR 350,000,000 bond issuance

The banks acted as arrangers and bookrunners in connection with Heimstaden AB’s (publ) issuance of EUR 350,000,000 senior unsecured bonds, within a framework amount of EUR 450,000,000.

Vinge advised IVISYS on directed share issue

Vinge advised IVISYS AB (publ) in connection with a directed share issue through an accelerated book-building procedure.

Vinge advises Net Insight AB (publ)

Vinge advises Net Insight AB (publ) in connection with the signing of an agreement to divest its Resource Optimization business area, doing business as “ScheduALL“ to Xytech Systems Corp.

Vinge has advised VNV Global AB (publ) in connection with a directed share issue

Vinge has advised VNV Global AB (publ), an investment company listed on Nasdaq Stockholm, in connection with a directed share issue whereby VNV Global receives approximately SEK 1,166 million in issue proceeds.